Background: Early neurologic improvement (ENI) after intravenous thrombolysis is associated with favorable outcome, but associated serum biomarkers were not fully determined. We aimed to investigate the issue based on a prospective cohort.
Methods: In INTRECIS study, five centers were designed to consecutively collect blood sample from enrolled patients.
Background: Symptomatic intracranial hemorrhage (sICH) is a terrible complication after intravenous alteplase in stroke, and numerous biomarkers have been investigated. However, the change of biomarkers to sICH has not been well determined.
Aim: To investigate the association between the change of biomarkers and sICH.
Background: Symptomatic intracranial hemorrhage (sICH) after intravenous thrombolysis is closely related to the poor outcome of stroke.
Aims: To determine the serum biomarkers associated with sICH based on the INTRECIS study.
Methods: Enrolled patients with sICH and without any ICH were matched by propensity score matching with the ratio of 1:1.